loader image
In focus: Unlocking the potential of GPCR targets

In focus: Unlocking the potential of GPCR targets

GPCR representation, the tertiary structure of bovine rhodopsin within the cell membrane (in grey). Source: Wikimedia Commons PharmEnable has recently partnered with Sosei Heptares to work on a challenging G protein-coupled receptor (GPCR) target for a neurology...
PharmEnable wins Rising Star at UKBAA Angel Investment Award

PharmEnable wins Rising Star at UKBAA Angel Investment Award

We are delighted to announce that PharmEnable has been awarded Rising Star in the DeepTech Investment of the Year category at the UKBAA Angel Investment Awards 2021. The annual UKBAA Angel Investment awards, sponsored by Playfair Capital, recognise acknowledge the...
PharmEnable welcome new Director of Drug Discovery

PharmEnable welcome new Director of Drug Discovery

PharmEnable are delighted to welcome Dr James Dale as Director of Drug Discovery. Dr Dale has over 18 years of experience in research and drug discovery, focusing on identifying and delivering novel therapeutics. He earned a PhD in synthetic organic chemistry and has...